Literature DB >> 30607891

Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.

Cristina Valencia-Sanchez1, Kristen K Steenerson2, Katalin Kelemen3, Robert Orenstein4, Shimon Kusne4, Marie F Grill5.   

Abstract

Post-transplantation lymphoproliferative disorder (PTLD) is a complication of solid organ and hematopoietic stem cell transplantation. Cases with isolated central nervous system (CNS) disease are rare. Epstein-Barr virus (EBV) plays a causative role. We present a patient with EBV cerebellitis documented 5 months prior to development of primary CNS PTLD (PCNS-PTLD). This case report demonstrates progression from EBV CNS infection to lymphoproliferative disorder, highlighting the importance of serial clinical and imaging monitoring in transplant patients post-EBV CNS infection. PCNS-PTLD should always be considered in the differential diagnosis for transplant patients presenting with CNS symptoms, even in cases with no evidence of EBV viremia. Earlier diagnosis and appropriate treatment could result in improved outcomes.

Entities:  

Keywords:  Epstein-Barr virus encephalitis; Neurological complications solid organ transplant; Post-transplant lymphoproliferative disorder; Primary central nervous system lymphoma

Year:  2019        PMID: 30607891     DOI: 10.1007/s13365-018-0711-8

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  15 in total

1.  Epstein-Barr virus encephalitis in a renal allograft recipient diagnosed by polymerase chain reaction on cerebrospinal fluid and successfully treated with ganciclovir.

Authors:  R MacGinley; P B Bartley; T Sloots; D W Johnson
Journal:  Nephrol Dial Transplant       Date:  2001-01       Impact factor: 5.992

Review 2.  Epstein-Barr virus and the nervous system.

Authors:  P Portegies; N Corssmit
Journal:  Curr Opin Neurol       Date:  2000-06       Impact factor: 5.710

3.  Encephalitis caused by Epstein-Barr virus in a renal transplant recipient.

Authors:  Iñigo Garamendi; Miguel Montejo; Laura Cancelo; Leire Lopez; Koldo Aguirrebengoa; Alex Martín; Sofia Zarraga
Journal:  Clin Infect Dis       Date:  2002-01-15       Impact factor: 9.079

4.  Epstein-Barr virus encephalitis after kidney transplantation and successful treatment with brivudine.

Authors:  Tobias Lahmer; Dieter Hoffmann; Uwe Heemann; Claudius Küchle; Helga Frank
Journal:  Transpl Int       Date:  2010-01-12       Impact factor: 3.782

5.  Dysphagia and right leg weakness in a renal transplant patient.

Authors:  Melinda L Munang; Anupama Mutagi; Mark S Bailey; Husam Osman
Journal:  J Clin Virol       Date:  2013-04-10       Impact factor: 3.168

6.  EBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient.

Authors:  A Vaglio; L Manenti; C Mancini; E Chierici; R Cobelli; F Bacci; A Palmisano; C Buzio; L Bignardi; U Maggiore
Journal:  Am J Transplant       Date:  2010-04       Impact factor: 8.086

7.  Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.

Authors:  Timothy C Lee; John A Goss; Cliona M Rooney; Helen E Heslop; Neal R Barshes; Yvette M Caldwell; Adrian P Gee; Jaymee D Scott; Barbara Savoldo
Journal:  Clin Transplant       Date:  2006 Nov-Dec       Impact factor: 2.863

8.  Psychiatric symptoms and cognitive dysfunction caused by Epstein-Barr virus-induced encephalitis.

Authors:  Joachim Behr; Martin Schaefer; Eckhard Littmann; Randolf Klingebiel; Andreas Heinz
Journal:  Eur Psychiatry       Date:  2006-12       Impact factor: 5.361

9.  Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient.

Authors:  Michael Khalil; Christian Enzinger; Mirja Wallner-Blazek; Michael Scarpatetti; Alain Barth; Sabine Horn; Gudrun Reiter
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

10.  Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Authors:  Robert Cavaliere; Gina Petroni; Maria B Lopes; David Schiff
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.